A 57-year-old man was diagnosed with lung cancer and underwent pneumonectomy and mediastinal lymph node dissection. He was discharged without acute complications, but on a regular outpatient follow-up, he was readmitted with postpneumonectomy empyema. He was successfully treated with a vacuum-assisted closure device and for 1 year period of outpatient follow-up, there was no recurrence of empyema or lung cancer.
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CASE REPORT
A 57-year-old man visited Seoul National University
Hospital due to an incidentally detected hilar mass. It was a was performed to create enough space for the irrigation and debridement to follow. A vacuum-assisted closure (VAC) device was applied at postoperative day 1, and VAC sponge change was repeated at postoperative day 6, 9, and 12 ( Fig.   2) . Finally, the Clagett procedure completed by filling the pleural space with antibiotic solution at postoperative day 14 and the patient was discharged without complications (Fig.   1D ).
For a 1-year period of outpatient follow-up, the cavity was fully filled with pleural effusion, and there was no recurrence of empyema or lung cancer.
DISCUSSION
The treatment of postpneumonectomy empyema (PPE) remains a therapeutic challenge. The conventional management
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− 155 − of PPE is to create temporary thoracostoma, a well-known form of pleural drainage, which was first introduced in 1915
and has proven useful as a treatment for PPE [1] . It necessitates an open window, regular wound packing, frequent wound debridement, and prolonged hospitalization prior to definitive closure [2] .
Currently, a new modality of treatment for PPE is emerging: VAC. Since VAC therapy was introduced, an increasing number of publications can be found describing various possible uses of the therapy; however, few reports have described an intrathoracic application after Ditterich et al. first introduced the idea in 2006 [3] .
After thoracostoma was established in PPE patients, the extensive pleural secretions would require the dressings to be changed frequently; however, by using the VAC therapy system, secretions were collected in the device, so that it needed less frequent changes. In addition, the continuous removal of potentially infectious secretions from the wound and thoracic cavity supported the rapid healing of the initially septic conditions. Furthermore, if the patient was able to empty the device, he could be transferred to ambulatory care [4] .
In this case, daily cleaning or dressing was not necessary, and we changed the VAC sponge only 3 times over the course of 14 days, which was very convenient for both the doctors and patient. The postpneumonectomy space became clean enough for a Clagett procedure and the outcome was satisfactory without any short-or long-term treatment failure.
It is our opinion that the VAC system might be widely used as an alternative option for the treatment of PPE in the near future.
